<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

The Changing Landscape of the Pharmaceutical Industry: A Preview of Cytel’s Contributions at PHUSE EU 2023

| |


It feels like just yesterday I attended my first PHUSE conference back in 2005 in Heidelberg, Germany. Fast forward 19 years, and the pharmaceutical industry landscape has undergone significant transformations. In the world of statistical programming, data analysis, and clinical data science, the terminology and roles have evolved, allowing you to choose your preferred label. We’ve moved from a conference featuring 90 presentations, including posters, across 11 different streams to this year having more than 200 presentations spanning 18 streams. PHUSE EU will take place in Birmingham on November 5–8, 2023.

Back in 2005, the Clinical Data Interchange Standards Consortium (CDISC) was in its infancy, but it already had its dedicated stream, “CDISC and XML,” featuring 12 contributions. SAS was the predominant software at the time. Fast forward to this year and CDISC, data standards, and data submission are central themes, with dedicated streams like “Standards Implementation” and “Data Standards & Governance.” We also have multiple sessions focused on the user experience when submitting data to health authorities within the “Submission & Agencies” stream. Additionally, there is a wealth of presentations on implementations and use cases, especially within the “Script, Macros, and Automation” stream, which I will be co-leading with Elena Glathe and Willy Greenway.

The landscape is further changing with the growing influence of open-source tools, as evidenced by the adoption of new technologies and programming languages like R. The number of presentations addressing R and SAS topics is quite significant, with roughly 34 presentations discussing R use cases compared to 27 for SAS.

Cytel will make significant contributions this year again, including three presentations and one poster. The week kicks off with my biostatistics colleague, Parichay Srivastava, who will present “A Beginner’s Guide to Overcoming Attrition Bias in Clinical Research: The Method of Inverse Probability of Attrition Weighting (IPAW)” in the “Real-World Evidence” stream on Monday at 3 pm. Parichay will introduce attendees to IPAW, a potent technique to mitigate attrition bias in longitudinal studies when dealing with subjects dropping out or lost to follow-up.


GDD_PHUSE 2023_banner Srivastava

I will follow with my presentation, “Experiencing the FDA CBER,” in the “Submission and Agencies” stream at 4:30 pm on the same day. See my recent post detailing the topic.


GDD_PHUSE 2023_banner Tinazzi

On Tuesday at 4 pm, Sebastià Barcelo will present in the “Application Development” stream on “Leveraging the Analysis Results (ARS): The Cytel PRISM Experience.” This builds upon the presentation from my colleague Nicolas Rouillè last year, delving into how Cytel is utilizing existing artifacts metadata, such as table shells, providing more technical insights. We’re also excited to provide a demo of our PRISM tool at our booth.

GDD_PHUSE 2023_banner Barcelo

Additionally, we have a poster presentation on Tuesday at 5:30 pm, presented by Cedric Marchand, Global Head of Cytel Statistical Programming, where we’ll share our experiences in the “Migration to SAS Grid for 300 Users – From Preparation to Production.”


GDD_PHUSE 2023_banner Marchand

Cytel will have a booth at the conference, where you can engage in discussions with our Client Development Manager colleague, Jennifer Ellison, or with me, Parichay, Sebastià, Cedric, and our three other Statistical Programmer colleagues, Caroline Terril, Director of Statistical Programming, Gautham Selvaraj, Senior Manager of Statistical Programming, and Mbery Sene, Senior Statistical Programmer

We look forward to reuniting with colleagues and friends from around the world and meeting new acquaintances.


Will you be attending PHUSE EU on Nov. 5–8? Click below to book a meeting with our experts:


Book a Meeting


Read more from Perspectives on Enquiry and Evidence:

Sorry no results please clear the filters and try again

Preparing Your Integrated Summaries of Safety and Effectiveness: Best Practices

Written by Angelo Tinazzi and Florence Le Maulf Integrated Summaries of Safety (ISS) and Integrated Summaries of...
Read more

Presenting Clinical Data for Regulatory Submission: A Stats Perspective

Data submissions are very regulated, but every drug and drug development are different. Therefore, the data presented...
Read more

New Ebook: “The Good Data Doctor on Data Submission and Data Integration”

Regular technical discussions with the FDA play a critical role in ensuring data submission success. These discussions...
Read more


contact iconSubscribe back to top